Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tolerability and first hints for potential efficacy of motor-cognitive training under inspiratory hypoxia in health and neuropsychiatric disorders: A translational viewpoint.
Mennen SS, Franta M, Begemann M, Wilke JBH, Schröder R, Butt UJ, Cortés-Silva JA, Çakır U, Güra M, de Marées M, Gastaldi VD, Burtscher J, Schanz J, Bohn M, Burtscher M, Fischer A, Poustka L, Hammermann P, Stadler M, Lühder F, Singh M, Nave KA, Miskowiak KW, Ehrenreich H. Mennen SS, et al. Among authors: schanz j. Neuroprotection. 2024 Sep 1;2(3):228-242. doi: 10.1002/nep3.47. Epub 2024 Jun 4. Neuroprotection. 2024. PMID: 39404697 Free PMC article.
Evaluation of a novel, stand-alone system to measure interleukin-6.
Dierks S, Wiederhold M, Schanz J, Fischer A, Schnelle M. Dierks S, et al. Among authors: schanz j. Clin Chem Lab Med. 2023 Jan 27;61(7):e128-e130. doi: 10.1515/cclm-2022-1320. Print 2023 Jun 27. Clin Chem Lab Med. 2023. PMID: 36700413 Free article. No abstract available.
Feasibility of Continuous Infusion of Cefiderocol in Conjunction with the Establishment of Therapeutic Drug Monitoring in Patients with Extensively Drug-Resistant Gram-Negative Bacteria.
Prinz C, Streit F, Schumann C, Dudakova A, Lanckohr C, Schanz J, Bohn M, Groß U, Meissner K, Moerer O, Harnisch LO. Prinz C, et al. Among authors: schanz j. Clin Drug Investig. 2023 Apr;43(4):307-314. doi: 10.1007/s40261-023-01257-8. Epub 2023 Apr 5. Clin Drug Investig. 2023. PMID: 37017874 Free PMC article.
Humoral and cellular immune responses in fully vaccinated individuals with or without SARS-CoV-2 breakthrough infection: Results from the CoV-ADAPT cohort.
Hollstein MM, Dierks S, Schön MP, Bergmann A, Abratis A, Eidizadeh A, Kaltenbach S, Schanz J, Groß U, Leha A, Kröger A, Andag R, Zautner AE, Fischer A, Erpenbeck L, Schnelle M. Hollstein MM, et al. Among authors: schanz j. J Med Virol. 2023 Oct;95(10):e29122. doi: 10.1002/jmv.29122. J Med Virol. 2023. PMID: 37787583
Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real-world cohort of patients with lower-risk MDS.
Mazzeo P, Ganster C, Wiedenhöft J, Shirneshan K, Rittscher K, Brzuszkiewicz EB, Steinemann D, Schieck M, Müller-Thomas C, Treiber H, Braulke F, Germing U, Sockel K, Balaian E, Schanz J, Platzbecker U, Götze KS, Haase D. Mazzeo P, et al. Among authors: schanz j. Hemasphere. 2024 Sep 23;8(9):e70014. doi: 10.1002/hem3.70014. eCollection 2024 Sep. Hemasphere. 2024. PMID: 39315323 Free PMC article.
83 results